This is a preview of subscription content, log in via an institution to check access.
Notes
The study was supported by an unrestricted research grant from Pfizer.
Reference
Kuchenbecker U, et al. Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany. PLOS One : 24 May 2018. Available from: URL: https://doi.org/10.1371/journal.pone.0197905
Rights and permissions
About this article
Cite this article
Adult pneumococcal vaccination in Germany: alternative options. PharmacoEcon Outcomes News 805, 6 (2018). https://doi.org/10.1007/s40274-018-5008-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5008-x